Figure 2.

Schematic illustration of the generation of a three-dimensional (3D) immune tumor model for preclinical studies [1]. Tumor cells are cultured as a monolayer for 1–5 days to enable the formation of [2] 3D tumor spheroids [3]. Therapeutic antibodies (Abs) of different isotypes are applied separately to individual spheroids. (4a) Complement (C′)-containing medium is added to assess complement-dependent cytotoxicity (CDC). (4b) Human monocytes (Mo) are added to assess antibody-dependent cellular phagocytosis (ADCP).